Goldman Sachs’s Regulus Therapeutics RGLS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-130,339
Closed -$228K 5329
2025
Q1
$228K Sell
130,339
-82,040
-39% -$144K ﹤0.01% 4625
2024
Q4
$336K Buy
212,379
+33,374
+19% +$52.7K ﹤0.01% 4488
2024
Q3
$281K Buy
179,005
+40,540
+29% +$63.6K ﹤0.01% 4373
2024
Q2
$247K Sell
138,465
-88,954
-39% -$159K ﹤0.01% 4289
2024
Q1
$655K Buy
+227,419
New +$655K ﹤0.01% 3847
2021
Q2
Sell
-1,805
Closed -$28K 5527
2021
Q1
$28K Sell
1,805
-3,829
-68% -$59.4K ﹤0.01% 5185
2020
Q4
$76K Buy
+5,634
New +$76K ﹤0.01% 4509
2018
Q3
Sell
-139
Closed -$11K 4221
2018
Q2
$11K Buy
+139
New +$11K ﹤0.01% 4138
2017
Q3
Sell
-3,069
Closed -$363K 4378
2017
Q2
$363K Buy
3,069
+2,007
+189% +$237K ﹤0.01% 3700
2017
Q1
$210K Sell
1,062
-842
-44% -$166K ﹤0.01% 3936
2016
Q4
$514K Sell
1,904
-1,398
-42% -$377K ﹤0.01% 3441
2016
Q3
$1.31M Sell
3,302
-3,171
-49% -$1.26M ﹤0.01% 2916
2016
Q2
$2.25M Buy
6,473
+22
+0.3% +$7.63K ﹤0.01% 2548
2016
Q1
$5.36M Buy
6,451
+236
+4% +$196K ﹤0.01% 2034
2015
Q4
$6.5M Buy
6,215
+544
+10% +$569K ﹤0.01% 1898
2015
Q3
$4.45M Sell
5,671
-1,137
-17% -$892K ﹤0.01% 2077
2015
Q2
$8.95M Buy
6,808
+117
+2% +$154K ﹤0.01% 1743
2015
Q1
$13.6M Buy
6,691
+2,107
+46% +$4.28M ﹤0.01% 1503
2014
Q4
$8.82M Sell
4,584
-1,764
-28% -$3.39M ﹤0.01% 1670
2014
Q3
$5.2M Sell
6,348
-245
-4% -$201K ﹤0.01% 1960
2014
Q2
$6.36M Buy
6,593
+56
+0.9% +$54K ﹤0.01% 1838
2014
Q1
$7.08M Sell
6,537
-1,323
-17% -$1.43M ﹤0.01% 1775
2013
Q4
$6.97M Buy
7,860
+652
+9% +$578K ﹤0.01% 1776
2013
Q3
$8.16M Buy
7,208
+1,982
+38% +$2.24M ﹤0.01% 1609
2013
Q2
$6.15M Buy
+5,226
New +$6.15M ﹤0.01% 1644